1. Apelin/Apelin Receptor System: Molecular Characteristics, Physiological Roles, and Prospects as a Target for Disease Prevention and Pharmacotherapy
   Toshihiko Kinjo et al, 2020, Current Molecular Pharmacology CrossRef
2. Vascular effects of apelin: Mechanisms and therapeutic potential
   Amreen Mughal et al, 2018, Pharmacology & Therapeutics CrossRef
3. Elevated level of urinary tellurium is a potential risk for increase of blood pressure in humans and mice
   Tomoko Misawa et al, 2024, Environment International CrossRef
4. Adipokines, Vascular Wall, and Cardiovascular Disease
   Fabio Maresca et al, 2015, Angiology CrossRef
5. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells
   Mohamed I. Saad et al, 2015, Endocrine CrossRef
6. Enhanced A1 adenosine receptor-induced vascular contractions in mesenteric artery and aorta of in L-NAME mouse model of hypertension
   Vishal R. Yadav et al, 2019, European Journal of Pharmacology CrossRef
7. The effects of apelin treatment on a rat model of type 2 diabetes
   Raziye Akcılar et al, 2015, Advances in Medical Sciences CrossRef
8. The Emerging Potential of the Apelin-APJ System in Heart Failure
   Jonathan R. Dalzell et al, 2015, Journal of Cardiac Failure CrossRef
9. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome
   YUEZHONG LUO et al, 2014, Molecular Medicine Reports CrossRef
10. MicroRNA‐503 promotes angiotensin II‐induced cardiac fibrosis by targeting Apelin‐13
    Yuhong Zhou et al, 2016, Journal of Cellular and Molecular Medicine CrossRef
11. Effects of apelin on the cardiovascular system
    Anna Folino et al, 2015, Heart Failure Reviews CrossRef
12. Review: Apelin in disease
    Hanna Antushevich et al, 2018, Clinica Chimica Acta CrossRef
13. Aortic Stiffness in L-NAME Treated C57Bl/6 Mice Displays a Shift From Early Endothelial Dysfunction to Late-Term Vascular Smooth Muscle Cell Dysfunction
    Sofie De Moudt et al, 2022, Frontiers in Physiology CrossRef
14. Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis
    Sulé Gunter et al, 2018, Clinical Rheumatology CrossRef
15. Apelin/APJ system: a promising therapy target for hypertension
    Di Wu et al, 2014, Molecular Biology Reports CrossRef
16. Apelin/APJ system: A novel promising target for neurodegenerative diseases
    Huaiqing Luo et al, 2020, Journal of Cellular Physiology CrossRef
17. Apelin and its receptor APJ in cardiovascular diseases
    Xiao-Hua Yu et al, 2014, Clinica Chimica Acta CrossRef
18. A programmable protease-based protein secretion platform for therapeutic applications
    Xinyi Wang et al, 2024, Nature Chemical Biology CrossRef
19. Cooperative action of APJ and α1A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction
    Katsumasa Nagano et al, 2019, The Journal of Biochemistry CrossRef
20. Irisin improves perivascular adipose tissue dysfunction via regulation of the heme oxygenase-1/adiponectin axis in diet-induced obese mice
    Ningning Hou et al, 2016, Journal of Molecular and Cellular Cardiology CrossRef
21. Proteomic Assessment of C57BL/6 Hippocampi after Non-Selective Pharmacological Inhibition of Nitric Oxide Synthase Activity: Implications of Seizure-like Neuronal Hyperexcitability Followed by Tauopathy
    Jhana O. Hendrickx et al, 2022, Biomedicines CrossRef
22. Cardiovascular response to small-molecule APJ activation
    Brandon Ason et al, 2020, JCI Insight CrossRef
23. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)
    Hawa N. Siti et al, 2015, Vascular Pharmacology CrossRef
24. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
    Jiawei Song et al, 2021, Chinese Medical Journal CrossRef
25. Apelin/APJ expression in the heart and kidneys of hypertensive rats
    Rahime Sekerci et al, 2018, Acta Histochemica CrossRef
26. Chronic Inhibition of Nitric Oxide Synthases Impairs Spatiotemporal Learning and Memory to a Similar Extent in C57BL/6 and hAPP23+/− Mice
    Jhana O. Hendrickx et al, 2023, International Journal of Translational Medicine CrossRef
27. Resolvins as proresolving inflammatory mediators in cardiovascular disease
    Xavier Capó et al, 2018, European Journal of Medicinal Chemistry CrossRef
28. L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management
    Adeleh Sahebnasagh et al, 2022, Current Medicinal Chemistry CrossRef
29. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension
    Limei Liu et al, 2015, Journal of Cardiovascular Pharmacology CrossRef
30. Long-Term Pharmacological Inhibition of the Activity of All NOS Isoforms Rather Than Genetic Knock-Out of Endothelial NOS Leads to Impaired Spatial Learning and Memory in C57BL/6 Mice
    Jhana O. Hendrickx et al, 2021, Biomedicines CrossRef
31. Renal protective effects of induction of haem oxygenase‐1 combined with increased adiponectin on the glomerular vascular endothelial growth factor–nitric oxide axis in obese rats
    Xue Liu et al, 2015, Experimental Physiology CrossRef